sitagliptin phosphate

Known as: Sitagliptin Phosphate [Chemical/Ingredient], Phosphate Monohydrate, Sitagliptin, Monophosphate Monohydrate, Sitagliptin 
A pyrazine-derived DIPEPTIDYL-PEPTIDASE IV INHIBITOR and HYPOGLYCEMIC AGENT that increases the levels of the INCRETIN hormones GLUCAGON-LIKE PEPTIDE… (More)
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2016
2016
IMPORTANCE Previous trial results have suggested that dipeptidyl peptidase 4 inhibitor (DPP4i) use might increase heart failure… (More)
Is this relevant?
Highly Cited
2013
Highly Cited
2013
IMPORTANCE Acute pancreatitis has significant morbidity and mortality. Previous studies have raised the possibility that… (More)
  • table 1
  • table 2
Is this relevant?
Highly Cited
2012
Highly Cited
2012
OBJECTIVES The aim of this study was to investigate the antiatherogenic effects of the dipeptidyl peptidase-4 inhibitor, des… (More)
  • figure 1
  • figure 2
  • figure 3
  • figure 4
  • figure 5
Is this relevant?
2012
2012
BACKGROUND Recently, it has been suggested that enhancement of incretin effect improves cardiac function. We investigated the… (More)
  • figure 1
  • table 1
  • figure 2
  • figure 3
  • figure 4
Is this relevant?
Highly Cited
2011
Highly Cited
2011
OBJECTIVE Diet composition alters the metabolic states of adipocytes and hepatocytes in diabetes. The effects of dipeptidyl… (More)
  • figure 1
  • table 1
  • figure 2
  • figure 3
  • figure 4
Is this relevant?
2011
2011
Simple, accurate and precise spectroflourometric and spectrophotometric methods have been developed and validated for the… (More)
  • figure 1
  • figure 2
  • figure 3
  • table 1
  • table 2
Is this relevant?
Highly Cited
2008
Highly Cited
2008
OBJECTIVE We examined whether chronic administration of a glucagon-like peptide 1 (GLP-1) receptor agonist exendin-4 (Ex-4), a… (More)
  • figure 1
  • figure 2
  • figure 3
  • figure 4
  • figure 5
Is this relevant?
Highly Cited
2008
Highly Cited
2008
BACKGROUND Diabetes mellitus is common, costly, and increasingly prevalent. Despite innovations in therapy, little is known about… (More)
  • figure 1
  • figure 2
  • figure 3
  • figure 4
Is this relevant?
2007
2007
A series of beta-aminoamides bearing triazolopiperazines has been prepared and evaluated as potent, selective, orally active… (More)
Is this relevant?
2007
2007
Sitagliptin (MK-0431) is an orally active, potent, and selective dipeptidyl peptidase-4 inhibitor used for the treatment of… (More)
Is this relevant?